J K Pharmachem Ltd

Key Stats

Day's Price Range
52-Week Price Range

Company Financials

  • Annual
Value in ₹ crore

Peer Comparsion

Rank 76
Rank 77
Rank 83
Dividend Yield
Rank 42
Rank 120
Price To Book Ratio
Rank 64
Debt To Asset
Rank 83

Company Information

Jointly promoted by J K Industries and TIDCO J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.94 to partfinance the setting up of a plant to manufacture 1250 MMU P.a of pencillinG based on a microbial strain from the technical collaborators IGC Cyprus Cyprus a whollyowned subsidiary of ICN Galenika. Commercial production at this plant commenced in Oct.95. The company has a tieup with ICN Galenika part of the ICN Pharmaceuticals group one of the pioneering manufacturers of pencillinG to set up a 1250mmu capacity plant. It has already produced international standard penicillin with Indian raw materials at its collaborators plant which is among the best in the world. In addition J K Pharmachem had setup its own RD activity well in advance for future development in the field of biotechnology. A pilot plant is also being established for this purpose at Cuddalore Tamilnadu.The company also plans to diversify into speciality fermentation products. It has also started production of PenicillinV and is the only one in India to produce this bulk active.During 19992000 the company started the production of Penicillin V and is the only producer of this important bulk active in India. The accumulated losses of the company having exceeded 50 of the peak networth of the company in the immediately preceding four financial years the company took the necessary steps of SICA 1985. The company developed an inhouse and launched viz JKZyme an environment new product of paper pulp. Commercial trails are under way in India and abroad.The company has produced 1192 MMU of PenicillinG during the financial year 200304 and retained its status as the second largest producer with a market share of 24.
OrganisationJ K Pharmachem Ltd